Cargando…

Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update

Magnolol (MG) is one of the primary active components of Magnoliae officinalis cortex, which has been widely used in traditional Chinese and Japanese herbal medicine and possesses a wide range of pharmacological activities. In recent years, attention has been drawn to this component due to its poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yiping, Li, Yuke, Zeng, Yuanlian, Tian, Bin, Qu, Xiaolan, Yuan, Qianghua, Song, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010308/
https://www.ncbi.nlm.nih.gov/pubmed/33815113
http://dx.doi.org/10.3389/fphar.2021.632767
_version_ 1783673036022480896
author Lin, Yiping
Li, Yuke
Zeng, Yuanlian
Tian, Bin
Qu, Xiaolan
Yuan, Qianghua
Song, Ying
author_facet Lin, Yiping
Li, Yuke
Zeng, Yuanlian
Tian, Bin
Qu, Xiaolan
Yuan, Qianghua
Song, Ying
author_sort Lin, Yiping
collection PubMed
description Magnolol (MG) is one of the primary active components of Magnoliae officinalis cortex, which has been widely used in traditional Chinese and Japanese herbal medicine and possesses a wide range of pharmacological activities. In recent years, attention has been drawn to this component due to its potential as an anti-inflammatory and antitumor drug. To summarize the new biological and pharmacological data on MG, we screened the literature from January 2011 to October 2020. In this review, we provide an actualization of already known anti-inflammatory, cardiovascular protection, antiangiogenesis, antidiabetes, hypoglycemic, antioxidation, neuroprotection, gastrointestinal protection, and antibacterial activities of MG. Besides, results from studies on antitumor activity are presented. We also summarized the molecular mechanisms, toxicity, bioavailability, and formulations of MG. Therefore, we provide a valid cognition of MG.
format Online
Article
Text
id pubmed-8010308
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80103082021-04-01 Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update Lin, Yiping Li, Yuke Zeng, Yuanlian Tian, Bin Qu, Xiaolan Yuan, Qianghua Song, Ying Front Pharmacol Pharmacology Magnolol (MG) is one of the primary active components of Magnoliae officinalis cortex, which has been widely used in traditional Chinese and Japanese herbal medicine and possesses a wide range of pharmacological activities. In recent years, attention has been drawn to this component due to its potential as an anti-inflammatory and antitumor drug. To summarize the new biological and pharmacological data on MG, we screened the literature from January 2011 to October 2020. In this review, we provide an actualization of already known anti-inflammatory, cardiovascular protection, antiangiogenesis, antidiabetes, hypoglycemic, antioxidation, neuroprotection, gastrointestinal protection, and antibacterial activities of MG. Besides, results from studies on antitumor activity are presented. We also summarized the molecular mechanisms, toxicity, bioavailability, and formulations of MG. Therefore, we provide a valid cognition of MG. Frontiers Media S.A. 2021-03-17 /pmc/articles/PMC8010308/ /pubmed/33815113 http://dx.doi.org/10.3389/fphar.2021.632767 Text en Copyright © 2021 Lin, Li, Zeng, Tian, Qu, Yuan and Song. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lin, Yiping
Li, Yuke
Zeng, Yuanlian
Tian, Bin
Qu, Xiaolan
Yuan, Qianghua
Song, Ying
Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
title Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
title_full Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
title_fullStr Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
title_full_unstemmed Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
title_short Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
title_sort pharmacology, toxicity, bioavailability, and formulation of magnolol: an update
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010308/
https://www.ncbi.nlm.nih.gov/pubmed/33815113
http://dx.doi.org/10.3389/fphar.2021.632767
work_keys_str_mv AT linyiping pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate
AT liyuke pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate
AT zengyuanlian pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate
AT tianbin pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate
AT quxiaolan pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate
AT yuanqianghua pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate
AT songying pharmacologytoxicitybioavailabilityandformulationofmagnololanupdate